From Surf Wiki (app.surf) — the open knowledge base
Perindopril/indapamide
Combination medication
Combination medication
| Field | Value |
|---|---|
| verifiedrevid | 464199158 |
| type | combo |
| image | Perindopril and indapamide.svg |
| image_class | skin-invert-image |
| component1 | Perindopril |
| class1 | ACE inhibitor |
| component2 | Indapamide |
| class2 | Thiazide-like diuretic |
| tradename | Preterax, Noliprel, Coversyl Plus |
| pregnancy_AU | |
| routes_of_administration | By mouth |
| ATC_prefix | C09 |
| ATC_suffix | BA04 |
| legal_AU | S4 |
| legal_CA | Rx-only |
| legal_CA_comment | |
| legal_UK | |
| legal_US | |
| legal_status | Rx-only |
| CAS_number | 182176-83-6 |
| PubChem | 9940214 |
| DrugBank_Ref | |
| ChemSpiderID_Ref | |
| ChemSpiderID | 8115834 |
Perindopril/indapamide (marketed as Preterax, Coversyl Plus and Noliprel) is a combination medication which contains perindopril (an ACE inhibitor) and indapamide (a thiazide-like diuretic) both of which are used for the treatment of essential hypertension (high blood pressure).
Medical uses
High blood pressure
Administration
One tablet daily, preferably to be taken in the morning and before a meal.
Elderly: Normal dosage.
Kidney failure: Creatinine clearance (CrCl) 30 mL/min: no dosage modification. If CrCl
Contraindications
Absolute contraindications to taking perindopril/indapamide include a known allergy to perindopril, indapamide, or sulfonamides; history of Quincke's edema linked to previous ACE inhibitor therapy; end-stage kidney disease; serious liver disease; high levels of potassium in the blood; pregnancy; and lactation.
Relative contraindications to using this medication include combination therapy with lithium, potassium salts, potassium-sparing diuretics, and certain medicines which can cause abnormal heart rhythms.
Side effects
Side effects of perindopril/indapamide may include weakness, dizziness, headache, mood swings and/or sleep disturbances. Additionally, cramps, low blood pressure, allergic reactions, skin rashes, gastrointestinal disorders, dry cough, erectile dysfunctions, dry mouth, and a risk of dehydration in the elderly and in people who have congestive heart failure.
Immunosuppressed patients. Hemodialysis: risk of anaphylactoid reaction during hemodialysis with polyacrylonitrile membranes. Liver impairment.
Caution is recommended when prescribing perindopril/indapamide to people with electrolyte disorders, diabetes, gout, low blood pressure, or strict sodium-free diets, heart or kidney failure, atherosclerosis, renal artery stenosis, and in elderly people.
Pharmacology
Using a fixed combination of an ACE inhibitor and a chlorosulfamoyl diuretic leads to additive synergy of the antihypertensive effects of the two constituents. Its pharmacological properties are derived from those of each of the components taken separately, in addition to those due to the additive synergistic action of the two constituents, when combined, on vascular endothelium, arteriolocapillary microcirculation, and the target organs of hypertension.
Drug interactions
Not recommended: combinations with lithium, potassium-sparing diuretics, potassium (salts), antiarrhythmic drugs which can cause torsades de pointes, anesthetic drugs, cytostatics or immunosuppressive agents.
References
References
- (7 July 2016). "Product monograph brand safety updates".
- (26 November 2014). "ABC of Hypertension". Wiley.
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Perindopril/indapamide — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report